The Linde Group has announced an agreement to install a CRYOHEAT system at SynTheAll Pharmaceuticals, a wholly owned subsidiary of WuXi PharmaTech in Shanghai.
CRYOHEAT is specifically designed to provide both the cooling and heating needs of process reaction vessels with a single unit, and will be supplied to WuXi PharmaTech, as a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the US.
The custom system is suitable for existing plant structures and for new builds. Under the terms of the contract, Linde will also supply engineering services, maintenance support and associated bulk gases.
“We envisage good global demand for our cryogenic technology. Our intimate knowledge of the industry, the ability of our engineers to understand key customer issues and Linde’s ability to provide custom solutions will drive future growth for us,” said Joe Eschbach, Head of Marketing Chemicals and Energy with the Gases Division of The Linde Group.
... to continue reading you must be subscribed
